Angewandte Chemie International Edition · 2013 · 40 citations · 19 references
PharmacyImmunologyMedicinal ChemistryAutoimmunityDrug DesignDrug DiscoveryCancer ImmunotherapyImmunomodulatory DrugsLigand BindingNon-hodgkin Lymphoma TherapySialic Acid LabelingSialylation In CancerSiglec Binding
Two changes for the better: A novel class of sialic acid derivatives is prepared by modifying both the C-4 and C-9 positions of Neu5Aα2Me (see structure). This approach gives a lead compound that has sub-micromolar affinity for Siglec-2 and may provide a pathway for immunoglycotherapy strategies for autoimmune diseases and B cell derived non-Hodgkin's lymphoma. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
19
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Weihsu C. Chen, Gladys C. Completo, Darren Sigal et al. · Blood · 2010 · 208 citations · Full text
Medicine, Cancer Biology, Oncology +16
Judith Gerlach, Reinhard Brossmer, Claus-Peter Danzer et al. · The Journal of Experimental Medicine · 2002 · 179 citations · Full text